Ethical approval for clinical trial from the Commission cantonal d’éthique de la recherche, CCER, of Geneva
We are pleased to inform, that the application for the clinical phase Ib/IIa study TargetAMD_IPE to the Ethical Commission of Geneva, CCER, has been successful. The application was submitted in February 2019 and on April 18th 2019 we received the ethical approval. We are now waiting for the consent of the regulatory authority Swissmedic to start the clinical trial.
9. May 2019
Categories: Target AMD